AI assistant
ELEVRA LITHIUM LIMITED — Share Issue/Capital Change 2006
Mar 30, 2006
64838_rns_2006-03-30_58c4c39a-7972-4780-9356-56dbea0e6943.pdf
Share Issue/Capital Change
Open in viewerOpens in your device viewer

DIAMONEX IMITED
Sky Level 301 Coronation Drive Milton Qld 4064 Australia
Telephone: +61 7 3369-6399 Facsimile: +61 7 3369-6077 e-mail: [email protected]
Postal Address: PO Box 1357 Milton Qld 4064
ASX ANNOUNCEMENTS AUSTRALIAN STOCK EXCHANGE
31 March 2006
RELEASE OF RESTRICTED SECURITIES
Attached is an Appendix 3B applying for quotation of the following securities on expiry of the relevant restriction period:
15,107,500 fully paid ordinary shares; and $\bullet$
ABN 26 091 951 978
$\bullet$ 11,727,500 options to acquire fully paid ordinary shares, exercisable at A\$0.20, expiring 30 June 2006.
Application will also be made to list the shares on the Botswana Stock Exchange. The company's options are not listed on the Botswana Exchange.
Diamonex Limited
$64$ $4 - 4$
Paul Crawford Company Secretary
For further information, contact:
Dan O'Neill (Managing Director) $+61$ 7 33696399 (Office)
$+61$ 7 33696077 (Fax) $+61407596942$ (Mobile) diamonex $@$ diamonex.com.au (Email)
Greg King (Chairman)
+61 7 33696399 (Office) +61 7 33696077 (Fax) $+61411473730$ (Mobile) [email protected] (Email)
DiamonEx is a Brisbane-based specialist diamond company planning to develop a diamond mine based on established resources at Martin's Drift, Botswana, within an area that produces 35% of the world's diamonds by value.
Rule 2.7, 3.10.3, 3.10.4, 3.10.5
Appendix 3B
New issue announcement, application for quotation of additional securities and agreement
Introduced 1/7/96. Origin: Appendix 5. Amended 1/7/98, 1/9/99, 1/7/2000, 30/9/2001, 11/3/2002, 1/1/2003.
| Name of entity | |||||
|---|---|---|---|---|---|
| DIAMONEX LIMITED | |||||
| ABN | |||||
| 26 091 951 978 | |||||
| We (the entity) give ASX the following information: | |||||
| Part 1 - All issue | |||||
| 1 | Class of securities issued or to be issued | ||||
| 2 | Number of securities issued or to be issued (if known) or maximum number which may be issued |
||||
| 3. | Principal terms of the securities | ||||
| 4 | Do the securities rank equally in all respects from the date of allotment with an existing class of quoted securities? |
||||
| 5 | Issue price or consideration | ||||
| 6 | Purpose of the issue | ||||
| 7 | Dates of entering securities into uncertificated holdings or despatch of certificates. |
||||
| 8 | Number and class of all securities quoted on ASX | Number | Class | ||
| 9. | Number and class of all securities not quoted on ASX. |
Number | Class | ||
| 10 | Dividend policy on the increased capital (interests) |
Part 2 - Bonus issue or pro rata issue
| 11 | Is security holder approval required? | |
|---|---|---|
| 12 | Is the issue renounceable or non-renounceable? | |
| 13 | Ratio in which the securities will be offered | |
| 14 | Class of securities to which the offer relates | |
| 15 | Record date to determine entitlements | |
| 16 | Will holdings different on registers $($ or subregisters) be aggregated for calculating entitlements? |
|
| 17 | Policy for deciding entitlements in relation to fractions |
|
| 18 | Names of countries in which the entity has security holders who will not be sent new issue documents |
|
| 19 | Closing date for receipt of acceptances or renunciations |
|
| 20 | Names of any underwriters | |
| 21 | Amount of any underwriting fee or commission | |
| 22 | Names of any brokers to the issue | |
| 23 | Fee or commission payable to the broker to the issue |
|
| 24 | Amount of any handling fee payable to brokers who lodge acceptances or renunciations on behalf of security holders |
|
| 25 | If the issue is contingent on security holders' approval, the date of the meeting |
|
| 26 | acceptance form and Date entitlement and prospectus or Product Disclosure Statement will be sent to persons entitled |
|
| 27 | If the entity has issued options, and the terms entitle option holders to participate on exercise, the date on which notices will be sent to option holders |
|
| 28 | Date rights trading will begin (if applicable) | |
| 29 | Date rights trading will end (if applicable) | |
| 30 | How do security holders sell their entitlements in full through a broker? |
- $31$ How do security holders sell part of their entitlements through a broker and accept for the balance?
- How do security holders dispose of th 32 entitlements (except by sale through a broker)?
- 33 Despatch date
Part 3 - Quotation of securities
- $34$ Type of securities (tick one)
- $(a)$ Securities described in Part 1
- $(b)$ $\mathbf{x}$ All other securities
Entities that have ticked box 34(a)
Additional securities forming a new class of securities
Tick to indicate you are providing the information or documents
If the securities are equity securities, the names of the 20 largest holders of the additional 35 securities, and the number and percentage of additional securities held by those holders If the securities are equity securities, a distribution schedule of the additional securities setting 36 out the number of holders in the categories $1 - 1,000$ $1,001 - 5,000$ $5,001 - 10,000$ $10.001 - 100.000$ $100.001$ and over 37 A copy of any trust deed for the additional securities
Entities that have ticked box 34(b)
| 38 | Number of securities for which quotation is sought | 15,107,500 | |
|---|---|---|---|
| 11,727,500 | |||
| 39. | Class of securities for which quotation is sought | fully paid ordinary shares | |
| June 2006 | options, exercisable at \$0.20, expiring 30 | ||
| 40 | Do the securities rank equally in all respects from the date of allotment with an existing class of quoted securities? |
YES | |
| 41 | Reason for request for quotation now | Release of restricted securities | |
| Number | Class | ||
| 42 | Number and class of all securities quoted on ASX (including the securities in clause 38) |
66,245,127 | Ordinary Shares |
| 30 441 500. | Ontione |
| . | |
|---|---|
| eir | |
Quotation agreement
- $\mathbf{1}$ Quotation of our additional securities is in ASX's absolute discretion. ASX may quote the securities on any conditions it decides.
- $\overline{2}$ We warrant the following to ASX.
- The issue of the securities to be quoted complies with the law and is not for an illegal ٠ purpose.
- There is no reason why those securities should not be granted quotation.
- An offer of the securities for sale within 12 months after their issue will not require disclosure under section $707(3)$ or section $1012C(6)$ of the Corporations Act.
- Section 724 or section 1016E of the Corporations Act does not apply to any applications received by us in relation to any securities to be quoted and that no-one has any right to return any securities to be quoted under sections 737, 738 or 1016F of the Corporations Act at the time that we request that the securities be quoted.
- We warrant that if confirmation is required under section 1017F of the Corporations Act in relation to the securities to be quoted, it has been provided at the time that we request that the securities be quoted.
- If we are a trust, we warrant that no person has the right to return the securities to be quoted under section 1019B of the Corporations Act at the time that we request that the securities be quoted.
- $\overline{3}$ We will indemnify ASX to the fullest extent permitted by law in respect of any claim, action or expense arising from or connected with any breach of the warranties in this agreement.
- We give ASX the information and documents required by this form. If any information or $\overline{4}$ document not available now, will give it to ASX before quotation of the securities begins. We acknowledge that ASX is relying on the information and documents. We warrant that they are (will be) true and complete.
$84$ $-4$
Sign here:
Date: 31 March 2006 (Director/Company Secretary)
Print name: PAUL CRAWFORD